Uncategorized

Top analyst calls Palantir too big to ignore, resets rating

For years, Wolfe Research maintained a long-standing avoidance strategy on Palantir (PLTR), keeping a bearish “Underperform” rating on the stock due to concerns over its steep valuation multiples. On Tuesday, June 16, that changed, though not by much. Wolfe analysts Alex Zukin and Joshua Tilton lifted their rating on Palantir (PLTR) to Peer Perform from

Top analyst calls Palantir too big to ignore, resets rating Read More »

Phantom Obesity: The Dark Side of Weight Loss

Rapid weight‑loss drugs like GLP‑1s are changing lives — and health care — but there’s an often‑overlooked psychological cost. In this interview, Thomas Rutledge, PhD. explains the “neglected psychology” that can follow dramatic, fast body changes: phantom obesity, body image mismatch, and emotional and social consequences similar to those seen after bariatric or cosmetic surgery.

Phantom Obesity: The Dark Side of Weight Loss Read More »